INTRODUCTION
Many different cell types, including the neutrophilic polymorphonuclear leucocytes (neutrophils), release arachidonic acid in response to stimulation. The fatty acid is then metabolized to generate one or more biologically active eicosanoids such as prostaglandins, thromboxanes and leukotrienes (Lands & Samuelsson, 1968; Hirata et al., 1979; Billah et al., 1980; Corey et al., 1980; Rubin et al., 1981; Feinstein & Sha'afi, 1983; Flower, 1985; Alonso et al., 1986; Burch et al., 1986; Pollock et al., 1986; Smith & Waite, 1986; Godfrey et al., 1987) . Although the steps involved in the release of arachidonic acid from membrane phospholipids after cell stimulation are complex and not fully understood, the main step involves the action of phospholipase A2 (PLA2). Because the concentration of free arachidonic acid is low, the rate-limiting step in eicosanoid biosynthesis is the liberation of arachidonic acid (Irvine, 1982) .
The various parameters that activate and regulate the PLA2 activity are not well understood. PLA2 activity has been assessed directly, and the evidence obtained from these studies suggests that Ca21 is necessary for the activities of the various cellular PLA2s. The concentration of Ca2" required for optimal activation of PLA2 in vitro is significantly higher than that obtained in cells after stimulation (Feinstein & Sha'afi, 1983 ).
The present studies were undertaken to examine three main questions. First, is the rise in the intracellular concentration of free Ca2+ produced by physiological stimuli such as platelet-activating factor (PAF) sufficient to release arachidonic acid? Second, do compounds that activate protein kinase C (PKC) potentiate the stimulated release of arachidonic acid? Third, is the potentiation, if any, mediated through PKC?
MATERIALS AND METHODS Preparation of cells
Rabbit neutrophils (4 h exudate) (neutrophils obtained from 12-14 h exudate were much less responsive) were collected, washed and suspended in Hanks' Balanced Salt Solution buffered with 10 mM-Hepes (pH 7.4) as previously described (Matsumoto et al., 1988) . Unless specified, the cells were incubated with 0.5,ug of pertussis toxin/ml for 1 h, 20 ng of phorbol 12-myristate 13-acetate (PMA)/ml for 3 min, or 25 /tM- (Volpi et al., 1984) . Briefly, [3H]arachidonic acid was sampled into a round-bottom flask, the ethanol was evaporated with a stream of N2, and immediately a known volume of a cell suspension (108 cells/ml) was added. The cell suspension was incubated at 37°C for 30 min, and then they were pelleted by centrifugation (750 g for 5 min), and the packed cells were washed twice and resuspended in Hanks' buffer (108 cells/ml). The reaction was initiated by adding a known volume of the stimulus, and it was stopped by the addition of 5 ml of hexane/propan-2-ol (3:2, v/v).
Abbreviations used: PKC, protein kinase C; H-7, 1-(5-isoquinolinesulphonyl)-2-methylpiperazine; PMA, phorbol 12-myristate 13-acetate; R59022, 6-(2-{4-[(4-fluorophenyl)phenylmethylene]-l-piperidinyl}ethyl)-7-methyl-5H-thiazolo-[3,2-]pyrimidin-5-one; f.Met-Leu-Phe, formylmethionyl-leucylphenylalanine; PAF, platelet-activating factor; PLA2, phospholipase A2.
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Isolation and separation of lipids Lipids were isolated and separated as previously described (Volpi et al., 1984) . After the reaction was terminated, the samples were vortex-mixed and kept overnight at 4 'C. The following day, the samples were again vortex-mixed for 1 min and centrifuged at 800 g for 5 min. The upper organic phase was removed and transferred to another set of test tubes. Portions (2 ml) of hexane were added to the remaining water phase, and the tubes were again vortex-mixed for 15 s and centrifuged as above. The top hexane layer was removed and pooled with the previous one. The organic phase was dried under a stream of N2, and the lipids were dissolved in 100 ,ul of hexane/propan-2-ol (3: 2, v/v).
To separate neutral lipids, 20 ,ul samples were spotted on silica-gel-60-precoated t.l.c. plates. Arachidonic acid (1.75 /ag) was added at the origin with the samples to help in the detection of the lipids with 12 vapour. The plates were developed in chloroform/acetone (24: 1, v/v). After exposure to the 12 vapour, the arachidonic acid was circled with a pencil, the plate was sprayed ligh-tly with water, and the corresponding silica gel was carefully scraped from the plate with a razor blade, collected, and assayed for radioactivity.
Fluorescence measurements
The cells were loaded with quin 2 as previously described (Naccache et al., 1986) . At the end of the loading period, the desired number of cells was washed once, and resuspended in Hanks' balanced salt solution. Fluorescence measurements were performed in an SLM (model 8000) fluorescence spectrophotometer. Chemicals fMet-Leu-Phe, quin 2/AM and PAF were purchased from Sigma (St. Louis, MO, U.S.A.), cytochalasin B was from Aldrich Chemical Co. (Milwaukee, WI, U.S.A.), H-7 from Seikagaku America (St. Petersburg, FL, U.S.A.), the diacylglycerol kinase inhibitor R59022 from Janssen Life Science Section (Piscataway, NJ, U.S.A.), PMA from CRC Cancer Biochemicals (Brewster, NY, U.S.A.), and the radioactive materials were from New England Nuclear. Pertussis toxin was a gift from Dr. J. J. Munoz, NIH Rocky Mountain Laboratory (Hamilton, MT, U.S.A.). Verghese et al., 1987) neutrophils stimulated with PAF were measured. The results are shown in Fig. 5 Table 2 clearly show that, although PMA has no effect on the basat extent of a&achidonkc acid release, it inhibits that produced by fMet-Leu-Phe R59022-treated rabbit neutrophils stimulated with fMetLeu-Phe. R59022 increases the concentration of diacylglycerol (Fig. 6 ) in neutrophils stimulated with fMet-Leu-Phe. Next, the release of arachidonic acid in control and R59022-treated cells stimulated by fMetLeu-Phe were measured, and the results are summarized in Table 4 . These data clearly show that R59022 potentiates arachidonic acid release produced by fMetLeu-Phe. Note that this potentiation is not inhibited by H-7, and in fact it is increased in H-7-treated neutrophils (P < 0.01).
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DISCUSSION
The addition of fMet-Leu-Phe or PAF to rabbit neutrophils causes the release of incorporated radiolabelled arachidonic acid. The release is rapid, transient and dose-dependent (Figs. 1-4) , and their actions can be greatly potentiated by cytochalasin B (results not shown).
The results shown in Fig. 5 and Table 1 clearly show that [3H]arachidonic acid release, but not the increase in intracellular Ca2+, is almost totally inhibited in pertussistoxin-treated rabbit neutrophils stimulated with PAF. We and others have previously shown that several of the changes produced by phospholipase C activation are totally abolished in pertussis-toxin-treated neutrophils stimulated with PAF Verghese et al., 1987) . On the basis of this information and the data shown in Fig. 5 and Table 1 , it is reasonable to conclude that, at least for PAF, a rise in intracellular Ca2+ is not sufficient for arachidonic acid release. Furthermore, these results suggest that a functional pertussis-toxin-sensitive guanine nucleotide regulatory protein and/or one or more of the changes produced by phospholipase C activation are necessary for the arachidonic acid release in rabbit neutrophils stimulated by PAF.
We have reported previously that the addition of PMA to intact rabbit neutrophils potentiates [3H]arachidonic acid release by the calcium ionophore A23187 (Volpi et al., 1985) . This potentiation is not inhibited by H-7 (Matsumoto et al., 1988) . Similar results have been found in platelets (Halenda et al., 1985; Mobley & Tai, 1985) . These results have been confirmed in the present 1989 studies (results not shown). This enhancing effect is not due to PMA action on the metabolism of arachidonic acid by either the lipoxygenase or the cyclo-oxygenase pathway (Halenda et al., 1985; McColl et al., 1986) or an inhibition of the activity of lysophosphatidylcholine acyltransferase (EC 2.3.1.23) (Matsumoto et al., 1988) . Although other interpretations are possible, it has been suggested, on the basis of these findings, that activation of PKC by PMA modulates positively the activity of PLA2.
With respect to the action of PMA on arachidonic acid release, several points can be made. First, PMA inhibits arachidonic acid release produced by either fMet-LeuPhe (> 30 %) or PAF (> 800%) (Table 2) . Second, H-7 does not affect the potentiation by PMA of A23187-induced arachidonic acid release (Matsumoto et al., 1988 ; those results were also confirmed in the present studies). Third, H-7 prevents the inhibition by PMA of arachidonic acid release in rabbit neutrophils stimulated by fMet-Leu-Phe or PAF. In fact, PMA increases significantly (P . 0.005) arachidonic acid release in H-7-treated cells stimulated with fMet-Leu-Phe. This potentiation could be due to an inhibition of protein kinase A by H-7. The inhibitory effect of PMA is at a point or points before the rise in intracellular Ca2+ produced by fMet-Leu-Phe and PAF Molski et al., 1988) .
In order to obtain further information on the role of PKC in arachidonic acid release in neutrophils stimulated by physiological agonists such as fMet-Leu-Phe, we made use of the diacylglycerol kinase inhibitor R59022. Stimulation of rabbit neutrophils by fMet-Leu-Phe produced a rapid and transient increase in diacylglycerol (Fig. 6 ). This increase is greatly potentiated in R59022-treated rabbit neutrophils. Arachidonic acid release is significantly greater in R59022-treated than in control rabbit neutrophils stimulated with fMet-Leu-Phe, and this potentiation is not inhibited, and in fact it is increased, in H-7-treated cells.
The results presented above make several important points.
1. Although an increase in intracellular Ca2+ is necessary, it is not sufficient for arachidonic acid release in rabbit neutrophils stimulated by physiological stimuli such as PAF.
2. In intact cells, a functional pertussis-toxin-sensitive guanine nucleotide regulatory (G) protein and/or one or more of the changes produced by phospholipase C activation are necessary for arachidonic acid release produced by physiological stimuli. A role for a pertussistoxin-sensitive G-protein in arachidonic acid release has been suggested by Axelrod et al. (1988) . They have found that, when added to dark-adapted transducin-depleted rod outer segments, the fy-subunits caused a marked increase in PLA2 activity, whereas addition of an equivalent amount of the ac-subunit caused only a slight increase (Axelrod et al., 1988) . The stimulatory action of fly-subunits can be due to their lipophilic nature, and it may not be due to the specific effect of the complex.
3. Agents that stimulate PKC potentiate arachidonic acid release, and this potentiation is not inhibited by the PKC inhibitor H-7. Although a role for PKC cannot be ruled out completely, the inability of H-7 to inhibit the observed potentiation by PMA or diacylglycerol suggests that these compounds produced their actions, in part, by direct membrane perturbation. A similar hypothesis was advanced for regulating arachidonate liberation in platelets in response to collagen at low intracellular free Ca2l concentrations (Pollock et al., 1986) .
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